Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
- Acheteur
- St James's Hospital, Dublin
- Pays
- Ireland
- Publié le
- 21 oct. 2026
- Date limite
- 19 nov. 2026 (première échéance des lots ; heure et fuseau dans l'avis officiel)
- Procédure
- open
- Nature du marché
- supplies
- Valeur estimée
- 375 000 € (somme des lots publiés)
- Lieu d'exécution (NUTS)
- IE061, IRL
- CPV
- 38000000 (Laboratory and optical equipment), 33696600 (Medical equipment and pharmaceuticals), 33696500 (Medical equipment and pharmaceuticals)
Description (langue d'origine)
The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancy. Currently this testing is divided among standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. While the laboratory is developing NGS based testing methodologies it is also seeking to secure access to reagents and consumables to continue to provide legacy clonality testing using capillary electrophoresis.
Un avis peut être rectifié ou annulé par l'acheteur. L'avis officiel publié sur TED fait toujours foi.
Source: TED, Publications Office of the EUCollecté le: